Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Topical tazarotene effective in congenital ichthyosis

Feb. 18, 2000

Antipsoriatic activity of EGF receptor tyrosine kinase inhibitor SU-5271

Feb. 15, 2000

Clearance to begin clinical trial of novel acne treatment sought by Praxis

Feb. 14, 2000

Hair growth promoter described by BMS for use in male pattern baldness

Feb. 9, 2000

Methods of wound healing using amphipathic peptides from Demegen

Feb. 8, 2000

New Sumitomo compounds inhibit cytokine and IgE production

Feb. 8, 2000

Cellegy to commence phase II trial of Anogesic as hemorrhoid treatment

Feb. 8, 2000

Alexion to commence development of 5G1.1 for treatment of dermatomyositis

Feb. 3, 2000

IGI and Fujisawa collaborate on topical formulations of dermatological product

Jan. 27, 2000

Micrologix Biotech commences phase I trial for acne therapy

Jan. 25, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.